Minirin
Polyuria, Nocturia, Polydipsia + 14 more
Treatment
17 Active Studies for Minirin
Treatment for
Polyuria
What is Minirin
Desmopressin
The Generic name of this drug
Treatment Summary
Desmopressin is a synthetic hormone used to control the amount of water in the body. It is typically used to treat conditions such as nocturnal enuresis (bed-wetting) and diabetes insipidus. It can also be used to treat mild cases of hemophilia and von Willebrand's disease. Desmopressin is available in various forms, including intranasal solution, intravenous solution, oral tablet, and oral lyophilisate. Nocdurna, a form of desmopressin acetate, was approved by the FDA in 2018 to treat nocturia
Ddavp
is the brand name
Minirin Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Ddavp
Desmopressin
1978
101
Effectiveness
How Minirin Affects Patients
Desmopressin is a drug that imitates the natural antidiuretic hormone (ADH) in the body. It works by stimulating receptors in the kidneys to absorb more water and produce less urine. Desmopressin is especially effective in increasing the activity of a protein called factor VIII, which is deficient in people with hemophilia and von Willebrand's disease Type I. Desmopressin does not have the same effect on blood pressure as ADH does. When taken as a nasal spray, desmopressin is less effective than when taken as an injection.
How Minirin works in the body
When desmopressin binds to special receptors in the cells of the distal tubules and collecting ducts of the nephron, it triggers a series of reactions in the cell. This causes more water channels (aquaporins) to be inserted into the membrane of the cell, which makes it more permeable to water.
When to interrupt dosage
The dosage of Minirin is contingent upon the diagnosed ailment, including Minor Surgical Procedures, Pituitary Gland and Surgery, Hemophilia A. The amount is dependent on the technique of delivery as stated in the table hereunder.
Condition
Dosage
Administration
Nocturia
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Polydipsia
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
von Willebrand Disease
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Hemophilia A
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Pituitary Diseases
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Uremia
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Hemorrhage
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
von Willebrand Disease
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Hemorrhage
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Hemophilia A
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Diabetes Insipidus, Neurogenic
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Pituitary Surgery
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Polyuria
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Nocturnal Enuresis
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Minor Surgical Procedures
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Polyuria
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Hemophilia A
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
Oral, , Tablet - Oral, Tablet, Nasal, Solution, Solution - Nasal, Solution - Intravenous, Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection - Intravenous, Injection, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Tablet, orally disintegrating, Sublingual, Tablet, orally disintegrating - Sublingual, Aerosol, metered - Nasal, Spray, metered - Nasal, Aerosol, metered, Tablet - Sublingual, Liquid, Solution - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Injection - Intravenous; Subcutaneous
Warnings
Minirin has three contraindications. It should not be taken when experiencing any of the conditions presented in the following table.
Minirin Contraindications
Condition
Risk Level
Notes
Hyponatremia
Do Not Combine
Renal Insufficiency
Do Not Combine
Hyponatremia
Do Not Combine
There are 20 known major drug interactions with Minirin.
Common Minirin Drug Interactions
Drug Name
Risk Level
Description
1-benzylimidazole
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 1-benzylimidazole.
2,5-Dimethoxy-4-ethylamphetamine
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 2,5-Dimethoxy-4-ethylamphetamine.
2,5-Dimethoxy-4-ethylthioamphetamine
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
4-Bromo-2,5-dimethoxyamphetamine
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 4-Bromo-2,5-dimethoxyamphetamine.
4-Methoxyamphetamine
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 4-Methoxyamphetamine.
Minirin Toxicity & Overdose Risk
Taking too much desmopressin can lead to low sodium levels in the blood (hyponatremia). Symptoms of hyponatremia can include seizures, confusion, drowsiness, headaches, irregular heartbeat, and swelling. If you have taken too much desmopressin, you should reduce the dose or stop using it altogether. You should also get your sodium levels checked and seek medical treatment.
Minirin Novel Uses: Which Conditions Have a Clinical Trial Featuring Minirin?
30 active investigations are examining the potential of Minirin to ameliorate Polyuria, Hemophilia A and Hemophilia B.
Condition
Clinical Trials
Trial Phases
Pituitary Diseases
0 Actively Recruiting
Hemorrhage
0 Actively Recruiting
Pituitary Surgery
0 Actively Recruiting
von Willebrand Disease
4 Actively Recruiting
Phase 3, Phase 1, Phase 2
Hemophilia A
2 Actively Recruiting
Phase 3, Phase 1
Uremia
0 Actively Recruiting
Nocturia
3 Actively Recruiting
Phase 4, Not Applicable
Polyuria
0 Actively Recruiting
Minor Surgical Procedures
0 Actively Recruiting
von Willebrand Disease
0 Actively Recruiting
Polydipsia
0 Actively Recruiting
Diabetes Insipidus, Neurogenic
2 Actively Recruiting
Phase 1, Early Phase 1
Hemophilia A
0 Actively Recruiting
Polyuria
0 Actively Recruiting
Hemorrhage
0 Actively Recruiting
Hemophilia A
0 Actively Recruiting
Nocturnal Enuresis
4 Actively Recruiting
Phase 3, Not Applicable
Minirin Reviews: What are patients saying about Minirin?
3.3
Patient Review
10/20/2015
Minirin for Bedwetting
Patient Q&A Section about minirin
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is Minirin used for?
"Minirin tablets are indicated to treat cranial diabetes insipidus and primary nocturnal enuresis (bedwetting) in patients from 6 years of age who are refractory to an alarm system or for whom an alarm system is not appropriate."
Answered by AI
Is Minirin over the counter?
"This medicine only requires a prescription from your doctor if you have low levels of specific agents that result in less bleeding."
Answered by AI
How do you give a Minirin?
"Place the Minirin Melt under your tongue. It will dissolve without needing any water. Please read the instruction leaflet that comes with the Minirin Melt."
Answered by AI
How long can you take Minirin for?
"The recommended amount of time to take Minirin Tablets for bedwetting is 3 months. After this period, it is recommended that you take a week break from the medication to see if the bedwetting has stopped. If it has not stopped, continue taking the medication for another 3 months. Your doctor will advise you on the best course of action."
Answered by AI